Bellevue Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-18,200
Closed -$846K 166
2023
Q2
$846K Buy
+18,200
New +$846K 0.01% 132